CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways 
SmileDirectClub to Report Third Quarter 2021 Results on November 8, 2021
NASHVILLE, Tenn., Oct. 18, 2021 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the...
HAMID ERFANAIN NAMED CHIEF EXECUTIVE OFFICER OF ENZO BIOCHEM TO ACCELERATE EXPANSION AND COMMERCIALIZATION OF KEY DIAGNOSTIC PLATFORMS
Dr. Elazar Rabbani to remain Chairperson of the Board and will assume new role as Chief Scientific Officer NEW YORK,...
Athenex and the Center for Cell and Gene Therapy Announce Allowance of Our First U.S. Patent Claims Around CAR-NKT Cell Therapy
Patent includes a pharmaceutical composition claim comprising a plurality of genetically modified CD62L-positive human NKT cells comprising at least one...
Saniona completes submission of manufacturing data for Tesomet capsules to U.S. FDA
PRESS RELEASE 18 October 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that...
Matica Subsidiary West Island Culture Signs Supply Agreement with Ontario
Toronto, Ontario--(Newsfile Corp. - October 18, 2021) - Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) ("Matica" or the...
NervGen Presents Interim Phase 1 Clinical Trial Data for NVG-291 at the American Neurological Association 14th Annual Meeting
NVG-291 Demonstrated to be Well Tolerated Along with a Favorable Pharmacokinetic ProfileVancouver, British Columbia--(Newsfile Corp. - October 18, 2021) -...
Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx(TM), into Brazil, Mexico, and Canada
Trial designed to investigate the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of,...
New Survey Shows Paradigm Shift in American Attitudes and Opinions About Mental Health Technology
Seventy-three percent of respondents are interested in scientifically proven mental health chatbots; usage trends show chatbots are a key component...
New Study Recommends the Use of Masimo PVi® to Guide Fluid Administration During Major Oncosurgery with Lung Ultrasonography
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of an abstract presented at ANESTHESIOLOGY 2021 in San Diego, in...
Core One Labs Applauds the City of Seattle in Their Efforts to Decriminalize Psylocibin and Other Natural Occuring Entheogenic Drugs
VANCOUVER, British Columbia, Oct. 16, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (FWB: LD6, WKN:...
Scientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity
LOS ANGELES, Oct. 15, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene modified cellular...
XORTX Therapeutics Announces Closing of US$12 Million Public Offering
CALGARY, Alberta, Oct. 15, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX | NASDAQ: XRTX),...
Avadel Pharmaceuticals Announces Ongoing FDA Review of NDA for FT218 for Patients with Narcolepsy
DUBLIN, Ireland, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to...
Cabaletta Bio Announces Presentation of Preclinical Data Supporting PLA2R-CAART as a Potential Precision Therapy for Antigen-Specific B Cell Depletion in PLA2R Membranous Nephropathy at ASN Kidney Week 2021
– Chimeric AutoAntibody Receptor (CAAR) T cells specifically recognized and eliminated anti-PLA2R antibody-expressing B cells in vitro – – Membrane proteome...
Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call During the American Society of Nephrology (ASN) Kidney Week 2021
Additional data to be presented from the ongoing phase 1/2 study of BION-1301 in patients with IgA nephropathy, including biomarker...
Nabriva Therapeutics to Present Data at CHEST Annual Meeting 2021
DUBLIN, Ireland and FORT WASHINGTON, Pa., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company...
Instadose Pharma Corp. Announces Vote
Instadose Pharma Corp. Announces Results of Annual and Special Meeting Including the Election of its Board of Directors and Approval...
Matica Announces Name Change and Share Consolidation
Toronto, Ontario--(Newsfile Corp. - October 15, 2021) - Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) ("Matica" or the...
Intellipharmaceutics Announces Third Quarter 2021 Results
TORONTO, ON / ACCESSWIRE / October 15, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a...
Unified Global to Acquire Its First Canadian Cannabis Dispensary Chain in Alberta
DENVER, CO & CALGARY, AB / ACCESSWIRE / October 15, 2021 / Unified Global Corp (OTC PINK:CHYL) ("Unified Global") announced...